AI Analysis AI Analysis of ATRC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ATRC to Watchlist?
Some Reasons Why To Add ATRC:
  • High gross margin of 75.5%
  • Low bankruptcy risk (Altman Z-Score: 7.53)
  • Highly efficient cash conversion (83% FCF/OCF ratio)
PDF

AtriCure stock upgraded to Buy Candidate
(Updated on Jul 17, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 02, 2026 Gain 9.94%

The AtriCure stock price fell by -1.88% on the last day (Friday, 17th Jul 2026) from $35.62 to $34.95. During the last trading day the stock fluctuated 3.00% from a day low at $34.86 to a day high of $35.90. The price has risen in 7 of the last 10 days and is up by 9.94% over the past 2 weeks. Volume has increased on the last day by 106 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 796 thousand shares were bought and sold for approximately $27.83 million.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $35.71 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 17.67% during the next 3 months and, with a 90% probability hold a price between $33.63 and $42.02 at the end of this 3-month period.

ATRC Signals & Forecast

The AtriCure stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.72 and $29.80. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 16, 2026, and so far it has fallen -1.88%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for AtriCure stock

On the downside, the stock finds support just below today's level from accumulated volume at $30.18 and $28.80. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AtriCure finds support just below today's level at $30.18. If this is broken, then the next support from accumulated volume will be at $28.80 and $27.98.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.05 between high and low, or 3.00%. For the last week, the stock has had daily average volatility of 3.39%.

Our recommended stop-loss: $33.79 (-3.31%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ATRC) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect AtriCure to open at $35.24, and during the day (based on 14 day Average True Range), to move between $34.26 and $35.64, which gives a possible trading interval of +/-$1.38 (+/-4.03%) up or down from last closing price. If AtriCure takes out the full calculated possible swing range there will be an estimated 4.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $35.62 (1.92%) than the support at $30.18 (13.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

AtriCure will release earnings AMC on Thursday, July 23, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.0300. We will update the financials statements for AtriCure, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.62% in the first trading day after earnings release.

Is AtriCure stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AtriCure stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.634 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $35.24 ( 0.82%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ATRC Performance

Trading levels for ATRC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 36.28 3.81%
R2 35.88 2.66%
R1 35.63 1.96%
Price 34.95
S1 34.84 -0.327%
S2 34.59 -1.03%
S3 34.19 -2.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 35.62 1.92%
Price 34.95
S1 30.18 -13.65%
S2 28.80 -17.60%
S3 27.98 -19.94%

FAQ

What is the symbol for AtriCure Stock and on which exchange is it traded?
The symbol for AtriCure is ATRC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AtriCure Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AtriCure stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy AtriCure Stock?
AtriCure Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AtriCure Stock.

What's the current price of AtriCure Stock?
As of the end of day on the Jul 17, 2026, the price of an AtriCure (ATRC) share was $34.95.

What is the 52-week high and low for AtriCure Stock?
The 52-week high for AtriCure Stock is $43.18 and the 52-week low is $25.37.

What is the market capitalization of AtriCure Stock?
As of the Jul 17, 2026, the market capitalization of AtriCure is 1.77B.

When is the next earnings date for AtriCure?
The upcoming earnings date for AtriCure is Jul 23, 2026.
Click to get the best stock tips daily for free!
ABOUT ATRICURE
AtriCure
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE